nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.295	1	CbGbCtD
Dinoprostone—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0254	0.107	CcSEcCtD
Dinoprostone—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0533	CcSEcCtD
Dinoprostone—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0428	CcSEcCtD
Dinoprostone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00906	0.0384	CcSEcCtD
Dinoprostone—PTGIR—hindbrain—amyotrophic lateral sclerosis	0.00857	0.0443	CbGeAlD
Dinoprostone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00832	0.0353	CcSEcCtD
Dinoprostone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0336	CcSEcCtD
Dinoprostone—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00735	0.0311	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0288	CcSEcCtD
Dinoprostone—HPGDS—embryo—amyotrophic lateral sclerosis	0.00657	0.034	CbGeAlD
Dinoprostone—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0265	CcSEcCtD
Dinoprostone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0265	CcSEcCtD
Dinoprostone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00612	0.0259	CcSEcCtD
Dinoprostone—HPGDS—brainstem—amyotrophic lateral sclerosis	0.00602	0.0311	CbGeAlD
Dinoprostone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0241	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.005	0.0212	CcSEcCtD
Dinoprostone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00497	0.021	CcSEcCtD
Dinoprostone—PTGIR—brainstem—amyotrophic lateral sclerosis	0.00491	0.0254	CbGeAlD
Dinoprostone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0191	CcSEcCtD
Dinoprostone—PTGER4—nervous system—amyotrophic lateral sclerosis	0.00431	0.0223	CbGeAlD
Dinoprostone—SLC51A—nervous system—amyotrophic lateral sclerosis	0.00424	0.0219	CbGeAlD
Dinoprostone—HPGDS—medulla oblongata—amyotrophic lateral sclerosis	0.0042	0.0217	CbGeAlD
Dinoprostone—PTGER1—nervous system—amyotrophic lateral sclerosis	0.00416	0.0215	CbGeAlD
Dinoprostone—PTGER4—central nervous system—amyotrophic lateral sclerosis	0.00415	0.0214	CbGeAlD
Dinoprostone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0175	CcSEcCtD
Dinoprostone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0174	CcSEcCtD
Dinoprostone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0173	CcSEcCtD
Dinoprostone—SLC51A—central nervous system—amyotrophic lateral sclerosis	0.00408	0.0211	CbGeAlD
Dinoprostone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0172	CcSEcCtD
Dinoprostone—PTGER1—central nervous system—amyotrophic lateral sclerosis	0.00401	0.0207	CbGeAlD
Dinoprostone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0165	CcSEcCtD
Dinoprostone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0162	CcSEcCtD
Dinoprostone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0161	CcSEcCtD
Dinoprostone—HPGDS—spinal cord—amyotrophic lateral sclerosis	0.00375	0.0193	CbGeAlD
Dinoprostone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00371	0.0157	CcSEcCtD
Dinoprostone—PTGER3—nervous system—amyotrophic lateral sclerosis	0.00365	0.0189	CbGeAlD
Dinoprostone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00355	0.015	CcSEcCtD
Dinoprostone—PTGER3—central nervous system—amyotrophic lateral sclerosis	0.00352	0.0182	CbGeAlD
Dinoprostone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0147	CcSEcCtD
Dinoprostone—Cough—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0146	CcSEcCtD
Dinoprostone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0145	CcSEcCtD
Dinoprostone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0143	CcSEcCtD
Dinoprostone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0143	CcSEcCtD
Dinoprostone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0143	CcSEcCtD
Dinoprostone—PTGER4—brain—amyotrophic lateral sclerosis	0.0033	0.017	CbGeAlD
Dinoprostone—SLC51A—brain—amyotrophic lateral sclerosis	0.00324	0.0167	CbGeAlD
Dinoprostone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0137	CcSEcCtD
Dinoprostone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0135	CcSEcCtD
Dinoprostone—HPGDS—nervous system—amyotrophic lateral sclerosis	0.00316	0.0163	CbGeAlD
Dinoprostone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0134	CcSEcCtD
Dinoprostone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0132	CcSEcCtD
Dinoprostone—SLCO1C1—spinal cord—amyotrophic lateral sclerosis	0.00306	0.0158	CbGeAlD
Dinoprostone—PTGIR—spinal cord—amyotrophic lateral sclerosis	0.00305	0.0158	CbGeAlD
Dinoprostone—HPGDS—central nervous system—amyotrophic lateral sclerosis	0.00304	0.0157	CbGeAlD
Dinoprostone—SLCO3A1—medulla oblongata—amyotrophic lateral sclerosis	0.00302	0.0156	CbGeAlD
Dinoprostone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00302	0.0128	CcSEcCtD
Dinoprostone—CYP11A1—medulla oblongata—amyotrophic lateral sclerosis	0.00296	0.0153	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0125	CcSEcCtD
Dinoprostone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0123	CcSEcCtD
Dinoprostone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0122	CcSEcCtD
Dinoprostone—PTGER3—brain—amyotrophic lateral sclerosis	0.00279	0.0144	CbGeAlD
Dinoprostone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0117	CcSEcCtD
Dinoprostone—SLCO4A1—medulla oblongata—amyotrophic lateral sclerosis	0.00275	0.0142	CbGeAlD
Dinoprostone—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.00274	0.0141	CbGeAlD
Dinoprostone—SLCO3A1—spinal cord—amyotrophic lateral sclerosis	0.00269	0.0139	CbGeAlD
Dinoprostone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0112	CcSEcCtD
Dinoprostone—SLCO1C1—nervous system—amyotrophic lateral sclerosis	0.00258	0.0133	CbGeAlD
Dinoprostone—PTGIR—nervous system—amyotrophic lateral sclerosis	0.00257	0.0133	CbGeAlD
Dinoprostone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0108	CcSEcCtD
Dinoprostone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0108	CcSEcCtD
Dinoprostone—SLCO1C1—central nervous system—amyotrophic lateral sclerosis	0.00249	0.0128	CbGeAlD
Dinoprostone—PTGIR—central nervous system—amyotrophic lateral sclerosis	0.00248	0.0128	CbGeAlD
Dinoprostone—SLCO4A1—spinal cord—amyotrophic lateral sclerosis	0.00246	0.0127	CbGeAlD
Dinoprostone—PTGIR—cerebellum—amyotrophic lateral sclerosis	0.00242	0.0125	CbGeAlD
Dinoprostone—HPGDS—brain—amyotrophic lateral sclerosis	0.00241	0.0125	CbGeAlD
Dinoprostone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0101	CcSEcCtD
Dinoprostone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00983	CcSEcCtD
Dinoprostone—SLCO3A1—nervous system—amyotrophic lateral sclerosis	0.00227	0.0117	CbGeAlD
Dinoprostone—SLCO2A1—nervous system—amyotrophic lateral sclerosis	0.00225	0.0116	CbGeAlD
Dinoprostone—CYP11A1—nervous system—amyotrophic lateral sclerosis	0.00223	0.0115	CbGeAlD
Dinoprostone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00937	CcSEcCtD
Dinoprostone—SLCO3A1—central nervous system—amyotrophic lateral sclerosis	0.00219	0.0113	CbGeAlD
Dinoprostone—SLCO2A1—central nervous system—amyotrophic lateral sclerosis	0.00217	0.0112	CbGeAlD
Dinoprostone—SLCO2B1—medulla oblongata—amyotrophic lateral sclerosis	0.00214	0.0111	CbGeAlD
Dinoprostone—CYP11A1—central nervous system—amyotrophic lateral sclerosis	0.00214	0.0111	CbGeAlD
Dinoprostone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00906	CcSEcCtD
Dinoprostone—SLCO3A1—cerebellum—amyotrophic lateral sclerosis	0.00214	0.011	CbGeAlD
Dinoprostone—SLCO4A1—nervous system—amyotrophic lateral sclerosis	0.00207	0.0107	CbGeAlD
Dinoprostone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00871	CcSEcCtD
Dinoprostone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00863	CcSEcCtD
Dinoprostone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00863	CcSEcCtD
Dinoprostone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00858	CcSEcCtD
Dinoprostone—SLCO4A1—central nervous system—amyotrophic lateral sclerosis	0.00199	0.0103	CbGeAlD
Dinoprostone—SLCO1C1—brain—amyotrophic lateral sclerosis	0.00197	0.0102	CbGeAlD
Dinoprostone—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00197	0.0102	CbGeAlD
Dinoprostone—PTGIR—brain—amyotrophic lateral sclerosis	0.00197	0.0102	CbGeAlD
Dinoprostone—SLCO4A1—cerebellum—amyotrophic lateral sclerosis	0.00195	0.0101	CbGeAlD
Dinoprostone—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.00194	0.01	CbGeAlD
Dinoprostone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00813	CcSEcCtD
Dinoprostone—SLCO2B1—spinal cord—amyotrophic lateral sclerosis	0.00191	0.00987	CbGeAlD
Dinoprostone—SLC22A7—brain—amyotrophic lateral sclerosis	0.00187	0.00966	CbGeAlD
Dinoprostone—SLC22A6—brain—amyotrophic lateral sclerosis	0.00181	0.00933	CbGeAlD
Dinoprostone—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00176	0.00908	CbGeAlD
Dinoprostone—SLCO3A1—brain—amyotrophic lateral sclerosis	0.00174	0.00897	CbGeAlD
Dinoprostone—SLCO2A1—brain—amyotrophic lateral sclerosis	0.00172	0.00888	CbGeAlD
Dinoprostone—CYP11A1—brain—amyotrophic lateral sclerosis	0.0017	0.00879	CbGeAlD
Dinoprostone—SLCO2B1—nervous system—amyotrophic lateral sclerosis	0.00161	0.00832	CbGeAlD
Dinoprostone—SLCO4A1—brain—amyotrophic lateral sclerosis	0.00158	0.00817	CbGeAlD
Dinoprostone—ABCC5—brain—amyotrophic lateral sclerosis	0.00157	0.00812	CbGeAlD
Dinoprostone—SLCO2B1—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00801	CbGeAlD
Dinoprostone—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00154	0.00795	CbGeAlD
Dinoprostone—SLCO2B1—cerebellum—amyotrophic lateral sclerosis	0.00151	0.00783	CbGeAlD
Dinoprostone—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00148	0.00765	CbGeAlD
Dinoprostone—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00148	0.00765	CbGeAlD
Dinoprostone—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.00145	0.00747	CbGeAlD
Dinoprostone—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00143	0.00737	CbGeAlD
Dinoprostone—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00143	0.00736	CbGeAlD
Dinoprostone—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00141	0.00731	CbGeAlD
Dinoprostone—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00139	0.0072	CbGeAlD
Dinoprostone—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00719	CbGeAlD
Dinoprostone—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00137	0.00709	CbGeAlD
Dinoprostone—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00703	CbGeAlD
Dinoprostone—SLCO2B1—brain—amyotrophic lateral sclerosis	0.00123	0.00636	CbGeAlD
Dinoprostone—SLC22A1—brain—amyotrophic lateral sclerosis	0.00118	0.00607	CbGeAlD
Dinoprostone—SLCO1A2—brain—amyotrophic lateral sclerosis	0.00113	0.00585	CbGeAlD
Dinoprostone—CYP19A1—brain—amyotrophic lateral sclerosis	0.00111	0.00571	CbGeAlD
Dinoprostone—ABCC4—brain—amyotrophic lateral sclerosis	0.00109	0.00563	CbGeAlD
Dinoprostone—SLC22A8—brain—amyotrophic lateral sclerosis	0.00108	0.00558	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—amyotrophic lateral sclerosis	0.000549	1	CrCbGaD
Dinoprostone—PTGIR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000208	0.000757	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000207	0.000754	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000205	0.000745	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0002	0.000729	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.0002	0.000727	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.0002	0.000727	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000198	0.000721	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000197	0.000718	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000196	0.000715	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000196	0.000715	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000196	0.000713	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000196	0.000712	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000195	0.000712	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000195	0.000712	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000195	0.00071	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000195	0.00071	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000192	0.000701	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000192	0.0007	CbGpPWpGaD
Dinoprostone—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000191	0.000695	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000191	0.000694	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00019	0.000691	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00019	0.000691	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00019	0.000691	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000189	0.000689	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000187	0.000682	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000186	0.000677	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000185	0.000675	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000185	0.000675	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000183	0.000667	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000183	0.000666	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000183	0.000666	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000183	0.000666	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000182	0.000663	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000181	0.000659	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000181	0.000659	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00018	0.000657	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00018	0.000655	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00018	0.000654	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000179	0.000653	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000179	0.000653	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000176	0.00064	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000175	0.000638	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000174	0.000635	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000174	0.000633	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000174	0.000633	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000173	0.000629	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000172	0.000627	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000171	0.000623	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000169	0.000616	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000168	0.000612	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000167	0.000609	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000167	0.000608	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000166	0.000605	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000164	0.000596	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000163	0.000595	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	0.000163	0.000594	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000163	0.000593	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000162	0.00059	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000162	0.00059	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000162	0.00059	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000161	0.000586	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00016	0.000583	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000159	0.00058	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000159	0.00058	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000159	0.000579	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000158	0.000574	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000158	0.000574	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000158	0.000574	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.000573	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000157	0.000571	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000156	0.000568	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000156	0.000566	CbGpPWpGaD
Dinoprostone—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000156	0.000566	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000155	0.000565	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000155	0.000564	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000155	0.000563	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000154	0.000559	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000153	0.000555	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00015	0.000547	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000149	0.000543	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000148	0.000538	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000146	0.000532	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000145	0.000526	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000143	0.000521	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000142	0.000517	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000142	0.000517	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00014	0.000511	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000139	0.000505	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000137	0.0005	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.000498	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.00049	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000134	0.000487	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000132	0.000482	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000132	0.000481	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000132	0.00048	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000132	0.00048	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000131	0.000477	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000131	0.000477	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000129	0.000471	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000128	0.000467	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000128	0.000467	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—APOE—amyotrophic lateral sclerosis	0.000127	0.000463	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000127	0.000461	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000124	0.000452	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000124	0.000451	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000123	0.000446	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000119	0.000433	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	0.000119	0.000432	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000118	0.000429	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000117	0.000427	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000116	0.000424	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000116	0.000424	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000115	0.00042	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.00042	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000419	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000114	0.000417	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000113	0.000412	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000407	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000111	0.000403	CbGpPWpGaD
Dinoprostone—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00011	0.000401	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.000394	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000108	0.000394	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000108	0.000394	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000108	0.000392	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.000387	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000105	0.000383	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00038	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000104	0.000379	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000104	0.000378	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000102	0.000371	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000102	0.000371	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	0.000102	0.00037	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000102	0.00037	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000102	0.00037	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000101	0.000368	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0001	0.000365	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	9.93e-05	0.000361	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.88e-05	0.00036	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.86e-05	0.000359	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.67e-05	0.000352	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.67e-05	0.000352	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.54e-05	0.000347	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.49e-05	0.000345	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.48e-05	0.000345	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.4e-05	0.000342	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.4e-05	0.000342	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	9.3e-05	0.000339	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	9.25e-05	0.000337	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.89e-05	0.000324	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.87e-05	0.000323	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.75e-05	0.000318	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.71e-05	0.000317	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.71e-05	0.000317	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.58e-05	0.000312	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.56e-05	0.000312	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.56e-05	0.000312	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.46e-05	0.000308	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.28e-05	0.000301	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.28e-05	0.000301	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.15e-05	0.000297	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.12e-05	0.000295	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8e-05	0.000291	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.98e-05	0.000291	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.95e-05	0.000289	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	7.86e-05	0.000286	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.83e-05	0.000285	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.83e-05	0.000285	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.78e-05	0.000283	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.78e-05	0.000283	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—amyotrophic lateral sclerosis	7.7e-05	0.00028	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.63e-05	0.000278	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.6e-05	0.000277	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.34e-05	0.000267	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.28e-05	0.000265	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.23e-05	0.000263	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.03e-05	0.000256	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.01e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.94e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.88e-05	0.00025	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.88e-05	0.00025	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.84e-05	0.000249	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	6.58e-05	0.00024	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.54e-05	0.000238	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.5e-05	0.000237	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.4e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.4e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.23e-05	0.000227	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.19e-05	0.000225	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.08e-05	0.000221	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.03e-05	0.000219	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.88e-05	0.000214	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.77e-05	0.00021	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.7e-05	0.000207	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.59e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.56e-05	0.000203	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.56e-05	0.000202	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.4e-05	0.000197	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	5.39e-05	0.000196	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.29e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.29e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.26e-05	0.000191	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.14e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.05e-05	0.000184	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.78e-05	0.000174	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.72e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.71e-05	0.000171	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.69e-05	0.000171	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.64e-05	0.000169	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	4.59e-05	0.000167	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.51e-05	0.000164	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.39e-05	0.00016	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.38e-05	0.000159	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.33e-05	0.000158	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.23e-05	0.000154	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.16e-05	0.000151	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.08e-05	0.000149	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.07e-05	0.000148	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.07e-05	0.000148	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.03e-05	0.000147	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.95e-05	0.000144	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.94e-05	0.000144	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.93e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.87e-05	0.000141	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.85e-05	0.00014	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.85e-05	0.00014	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.82e-05	0.000139	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.75e-05	0.000137	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	3.61e-05	0.000132	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.57e-05	0.00013	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.55e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.53e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.46e-05	0.000126	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.46e-05	0.000126	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.31e-05	0.000121	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.24e-05	0.000118	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.09e-05	0.000112	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.9e-05	0.000105	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.67e-05	9.71e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.62e-05	9.53e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.61e-05	9.5e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.61e-05	9.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.48e-05	9.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.27e-05	8.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.22e-05	8.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.12e-05	7.7e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.91e-05	6.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	6.39e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.44e-05	5.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.9e-06	3.6e-05	CbGpPWpGaD
